Incomplete penetrance in familial Alzheimer's disease with PSEN1 Ala260Gly mutation.


Journal

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
ISSN: 1590-3478
Titre abrégé: Neurol Sci
Pays: Italy
ID NLM: 100959175

Informations de publication

Date de publication:
Aug 2020
Historique:
received: 08 11 2019
accepted: 13 04 2020
pubmed: 25 4 2020
medline: 15 5 2021
entrez: 25 4 2020
Statut: ppublish

Résumé

Presenilin1 (PSEN1) gene is the most common known genetic cause of early-onset familial Alzheimer's disease. We describe an Italian family with the known p.Ala260Gly mutation in PSEN1 gene. The presence of an asymptomatic 64-year-old male carrying the mutation provides evidence of a possible incomplete penetrance leading to a wider range of age at onset. In order to evaluate whether or not epigenetic modifications could contribute to the phenotypic heterogeneity, we assessed global DNA methylation levels which resulted significantly higher in the three females than in their presymptomatic brother. The study suggests that DNA methylation can contribute to slowing down or possibly protecting from the manifestation of symptoms even in monogenic diseases, emphasizing the great complexity of familial Alzheimer's disease.

Identifiants

pubmed: 32328830
doi: 10.1007/s10072-020-04421-6
pii: 10.1007/s10072-020-04421-6
doi:

Substances chimiques

PSEN1 protein, human 0
Presenilin-1 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2263-2266

Subventions

Organisme : Ente Cassa di Risparmio di Firenze
ID : 2015.0713
Organisme : Airalzh onlus
ID : COOP
Organisme : Università di Firenze
ID : fondi ateneo per la ricerca

Auteurs

I Piaceri (I)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy.

A Chiari (A)

Department of Neuroscience, Neurology Unit, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.

C Galli (C)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy.
Care Department, AUSL Modena, Modena, Italy.

S Bagnoli (S)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy.

C Ferrari (C)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy.

S Trujillo Saavedra (ST)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy.

M A Molinari (MA)

Department of Neuroscience, Neurology Unit, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.

G Vinceti (G)

Department of Neuroscience, Neurology Unit, Azienda Ospedaliero Universitaria di Modena, Modena, Italy.
Department of Neuroscience, University of Modena and Reggio Emilia, Modena, Italy.

S Sorbi (S)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy.
IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy.

B Nacmias (B)

Department of Neuroscience, Psychology, Drug Research and Child Health and Centro di Ricerca, University of Florence, Florence, Italy. nacmias@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH